These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 17065639

  • 1. D-dimer testing to determine the duration of anticoagulation therapy.
    Palareti G, Cosmi B, Legnani C, Tosetto A, Brusi C, Iorio A, Pengo V, Ghirarduzzi A, Pattacini C, Testa S, Lensing AW, Tripodi A, PROLONG Investigators.
    N Engl J Med; 2006 Oct 26; 355(17):1780-9. PubMed ID: 17065639
    [Abstract] [Full Text] [Related]

  • 2. Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study.
    Cosmi B, Legnani C, Iorio A, Pengo V, Ghirarduzzi A, Testa S, Poli D, Tripodi A, Palareti G, PROLONG Investigators (on behalf of FCSA, Italian Federation of Anticoagulation Clinics).
    Eur J Vasc Endovasc Surg; 2010 Mar 26; 39(3):356-65. PubMed ID: 20034816
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.
    Cosmi B, Legnani C, Cini M, Guazzaloca G, Palareti G.
    Thromb Haemost; 2005 Nov 26; 94(5):969-74. PubMed ID: 16363238
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy.
    Zabczyk M, Plens K, Wojtowicz W, Undas A.
    Arterioscler Thromb Vasc Biol; 2017 Feb 26; 37(2):365-373. PubMed ID: 28062504
    [Abstract] [Full Text] [Related]

  • 8. Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study.
    Siragusa S, Malato A, Saccullo G, Iorio A, Di Ianni M, Caracciolo C, Coco LL, Raso S, Santoro M, Guarneri FP, Tuttolomondo A, Pinto A, Pepe I, Casuccio A, Abbadessa V, Licata G, Battista Rini G, Mariani G, Di Fede G.
    Am J Hematol; 2011 Nov 26; 86(11):914-7. PubMed ID: 21953853
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. D-Dimer Levels and Vitamin K Antagonist Therapy in Deep Vein Thrombosis of the Legs.
    Park JK, Koo do H, Yoon DH, Lee JN.
    Ann Vasc Surg; 2016 Jul 26; 34():119-34. PubMed ID: 27177705
    [Abstract] [Full Text] [Related]

  • 12. The negative predictive value of D-dimer on the risk of recurrent venous thromboembolism in patients with multiple previous events: a prospective cohort study (the PROLONG PLUS study).
    Ageno W, Cosmi B, Ghirarduzzi A, Santoro R, Bucherini E, Poli D, Prisco D, Alatri A, Pengo V, Galli L, Dentali F, Palareti G.
    Am J Hematol; 2012 Jul 26; 87(7):713-5. PubMed ID: 22488507
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study.
    Kearon C, Spencer FA, O'Keeffe D, Parpia S, Schulman S, Baglin T, Stevens SM, Kaatz S, Bauer KA, Douketis JD, Lentz SR, Kessler CM, Moll S, Connors JM, Ginsberg JS, Spadafora L, Julian JA, D-dimer Optimal Duration Study Investigators.
    Ann Intern Med; 2015 Jan 06; 162(1):27-34. PubMed ID: 25560712
    [Abstract] [Full Text] [Related]

  • 15. D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis.
    Cosmi B, Legnani C, Cini M, Guazzaloca G, Palareti G.
    Thromb Haemost; 2011 May 06; 105(5):837-45. PubMed ID: 21359409
    [Abstract] [Full Text] [Related]

  • 16. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J, Tosetto A, Marcucci M, Baglin T, Cushman M, Eichinger S, Palareti G, Poli D, Tait RC, Iorio A.
    Ann Intern Med; 2010 Oct 19; 153(8):523-31. PubMed ID: 20956709
    [Abstract] [Full Text] [Related]

  • 17. Deep vein thrombosis and pulmonary embolism.
    Di Nisio M, van Es N, Büller HR.
    Lancet; 2016 Dec 17; 388(10063):3060-3073. PubMed ID: 27375038
    [Abstract] [Full Text] [Related]

  • 18. Optimal duration of anticoagulation in patients with unprovoked venous thromboembolism: the impact of novel anticoagulants.
    Prandoni P, Milan M, Sarolo L, Zanon E, Bilora F.
    Int Angiol; 2017 Oct 17; 36(5):395-401. PubMed ID: 27982558
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anticoagulation period in idiopathic venous thromboembolism. How long is enough?
    Farraj RS.
    Saudi Med J; 2004 Jul 17; 25(7):848-51. PubMed ID: 15235686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.